These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Cross-reacting Candida albicans antigens in the pathogenesis of candidiasis]. Karaev ZO; Lebedeva TN; Mikhaĭlova NA Zh Mikrobiol Epidemiol Immunobiol; 1990 Oct; (10):106-9. PubMed ID: 1706123 [TBL] [Abstract][Full Text] [Related]
5. Longitudinal cell mediated immune responses and cross reactivity of lymphocytes from rabbits infected with Candida albicans. Shi YE J Tongji Med Univ; 1986; 6(2):89-92. PubMed ID: 3528515 [No Abstract] [Full Text] [Related]
6. Melanocytes and melanin represent a first line of innate immunity against Candida albicans. Tapia CV; Falconer M; Tempio F; Falcón F; López M; Fuentes M; Alburquenque C; Amaro J; Bucarey SA; Di Nardo A Med Mycol; 2014 Jul; 52(5):445-54. PubMed ID: 24934806 [TBL] [Abstract][Full Text] [Related]
7. Looking into Candida albicans infection, host response, and antifungal strategies. Wang Y Virulence; 2015; 6(4):307-8. PubMed ID: 25590793 [TBL] [Abstract][Full Text] [Related]
9. Antigenic variability between Candida albicans blastospores isolated from healthy subjects and patients with Candida infection. Poulain D; Tronchin G; Lefebvre B; Husson MO Sabouraudia; 1982 Sep; 20(3):173-7. PubMed ID: 6753187 [TBL] [Abstract][Full Text] [Related]
10. Antibody formation in experimental immunizations with Candida albicans ribosomal fractions. Segal E; Levy R; Eylan E Mycopathologia; 1978 Oct; 64(2):121-3. PubMed ID: 366424 [TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of innate immunity in resistance to Candida albicans. Tuite A; Mullick A; Gros P Genes Immun; 2004 Nov; 5(7):576-87. PubMed ID: 15372070 [TBL] [Abstract][Full Text] [Related]
12. [Development and evaluation of a new Candida albicans antigen]. Herrmann K; Rademacher KH Dermatol Monatsschr; 1983; 169(7):440-5. PubMed ID: 6414853 [No Abstract] [Full Text] [Related]
13. Humoral immune response to Candida albicans. Jones JM Immunol Ser; 1989; 47():375-400. PubMed ID: 2490083 [No Abstract] [Full Text] [Related]
14. CpG oligodeoxynucleotides increase the susceptibility of normal mice to infection by Candida albicans. Ito S; Pedras-Vasconcelos J; Klinman DM Infect Immun; 2005 Sep; 73(9):6154-6. PubMed ID: 16113339 [TBL] [Abstract][Full Text] [Related]
15. Assessment of immunoblotting in the investigation of specific immune responses during infection. Reen DJ Biochem Soc Trans; 1988 Apr; 16(2):132-4. PubMed ID: 3286316 [No Abstract] [Full Text] [Related]
16. Antigenic variability of Candida albicans cell surface. Cutler JE; Kanbe T Curr Top Med Mycol; 1993; 5():27-47. PubMed ID: 8242804 [No Abstract] [Full Text] [Related]
18. [Evaluation of cellular immune response in patients with recurrent candidiasis]. Carvalho LP; Bacellar O; Neves NA; Carvalho EM; de Jesus AR Rev Soc Bras Med Trop; 2003; 36(5):571-6. PubMed ID: 14576870 [TBL] [Abstract][Full Text] [Related]
19. Kinetics of antibody responses to cell wall mannan and a major cytoplasmic antigen of Candida albicans in rabbits and humans. Jones JM J Lab Clin Med; 1980 Nov; 96(5):845-60. PubMed ID: 6999104 [No Abstract] [Full Text] [Related]
20. [Changes in spontaneous rosette formation following incubation of lymphocytes with a specific antigen in candidiasis]. Karaev ZO; Sardyko NV; Golikova EA; Golubeva TN; Iarobkova ND Lab Delo; 1987; (12):915-8. PubMed ID: 2449575 [No Abstract] [Full Text] [Related] [Next] [New Search]